Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy

Maria B. Grant, E. Ann Ellis, Sergio Caballero, Robert N. Mames

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Plasminogen activator inhibitor-1 is secreted bidirectionally by endothelial cells, acts as the primary regulator of fibrinolysis and as a key modulator of extracellular matrix proteolysis. Elevated farum levels of plasminogen activator inhibitor-1 are observed in serum of diabetic individuals. We investigated whether plasminogen activator inhibitor-1 is overexpressed in capillaries of diabetic donors with nonproliferative retinopathy compared to non-diabetic donors. We also assessed plasminogen activator inhibitor-1 expression in an animal model of retinopathy induced by exposing rabbit retinas to insulin-like growth factor-I. Colloidal gold immunocytochemistry was used to quantify plasminogen activator-1 antigen in donor retinas from diabetic subjects (n = 10) and control subjects (n = 10). This technique was also used to examine expression of plasminogen activator inhibitor-1 for correlation with retinal changes in the insulin-like growth factor-I-induced retinopathy model (n = 14). Plasminogen activator inhibitor-1 immunoreactivity was significantly increased in the retinas of all diabetic subjects as compared to controls. In the rabbit model, the expression of plasminogen activator inhibitor-1 immunoreactivity correlated with pathological retinal changes. In both the diabetic human and insulin-like growth factor-1-injected rabbit, overproduction of plasminogen activator inhibitor-1 was seen within the lumen of capillaries, within the cytoplasm of endothelial cells and in the basement membrane and extracellular matrix surrounding these capillaries. Minimal plasminogen activator inhibitor-1 was detected in the retinas of non-diabetics and in control rabbits injected with either heat-inactivated insulin-like growth factor-I or balanced salt solution. These studies support the conclusion that plasminogen activator inhibitor-1 is overexpressed in the retinal capillaries of diabetics with nonproliferative diabetic retinopathy and in rabbits with insulin-like growth factor-I-induced retinopathy.

Original languageEnglish (US)
Pages (from-to)233-244
Number of pages12
JournalExperimental Eye Research
Volume63
Issue number3
DOIs
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Plasminogen Activator Inhibitor 1
Diabetic Retinopathy
Insulin-Like Growth Factor I
Retina
Rabbits
Extracellular Matrix
Endothelial Cells
Gold Colloid
Plasminogen Activators
Somatomedins
Fibrinolysis
Basement Membrane
Proteolysis
Cytoplasm
Animal Models
Salts
Hot Temperature
Immunohistochemistry
Antigens

Keywords

  • diabetic retinopathy
  • immunocytochemistry
  • insulin-like growth factor-I
  • plasminogen activator inhibitor
  • retinal endothelial cells

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy. / Grant, Maria B.; Ellis, E. Ann; Caballero, Sergio; Mames, Robert N.

In: Experimental Eye Research, Vol. 63, No. 3, 09.1996, p. 233-244.

Research output: Contribution to journalArticle

Grant, Maria B. ; Ellis, E. Ann ; Caballero, Sergio ; Mames, Robert N. / Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy. In: Experimental Eye Research. 1996 ; Vol. 63, No. 3. pp. 233-244.
@article{c95fe14ab8fc48c1934ced7b2874d592,
title = "Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy",
abstract = "Plasminogen activator inhibitor-1 is secreted bidirectionally by endothelial cells, acts as the primary regulator of fibrinolysis and as a key modulator of extracellular matrix proteolysis. Elevated farum levels of plasminogen activator inhibitor-1 are observed in serum of diabetic individuals. We investigated whether plasminogen activator inhibitor-1 is overexpressed in capillaries of diabetic donors with nonproliferative retinopathy compared to non-diabetic donors. We also assessed plasminogen activator inhibitor-1 expression in an animal model of retinopathy induced by exposing rabbit retinas to insulin-like growth factor-I. Colloidal gold immunocytochemistry was used to quantify plasminogen activator-1 antigen in donor retinas from diabetic subjects (n = 10) and control subjects (n = 10). This technique was also used to examine expression of plasminogen activator inhibitor-1 for correlation with retinal changes in the insulin-like growth factor-I-induced retinopathy model (n = 14). Plasminogen activator inhibitor-1 immunoreactivity was significantly increased in the retinas of all diabetic subjects as compared to controls. In the rabbit model, the expression of plasminogen activator inhibitor-1 immunoreactivity correlated with pathological retinal changes. In both the diabetic human and insulin-like growth factor-1-injected rabbit, overproduction of plasminogen activator inhibitor-1 was seen within the lumen of capillaries, within the cytoplasm of endothelial cells and in the basement membrane and extracellular matrix surrounding these capillaries. Minimal plasminogen activator inhibitor-1 was detected in the retinas of non-diabetics and in control rabbits injected with either heat-inactivated insulin-like growth factor-I or balanced salt solution. These studies support the conclusion that plasminogen activator inhibitor-1 is overexpressed in the retinal capillaries of diabetics with nonproliferative diabetic retinopathy and in rabbits with insulin-like growth factor-I-induced retinopathy.",
keywords = "diabetic retinopathy, immunocytochemistry, insulin-like growth factor-I, plasminogen activator inhibitor, retinal endothelial cells",
author = "Grant, {Maria B.} and Ellis, {E. Ann} and Sergio Caballero and Mames, {Robert N.}",
year = "1996",
month = "9",
doi = "10.1006/exer.1996.0112",
language = "English (US)",
volume = "63",
pages = "233--244",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy

AU - Grant, Maria B.

AU - Ellis, E. Ann

AU - Caballero, Sergio

AU - Mames, Robert N.

PY - 1996/9

Y1 - 1996/9

N2 - Plasminogen activator inhibitor-1 is secreted bidirectionally by endothelial cells, acts as the primary regulator of fibrinolysis and as a key modulator of extracellular matrix proteolysis. Elevated farum levels of plasminogen activator inhibitor-1 are observed in serum of diabetic individuals. We investigated whether plasminogen activator inhibitor-1 is overexpressed in capillaries of diabetic donors with nonproliferative retinopathy compared to non-diabetic donors. We also assessed plasminogen activator inhibitor-1 expression in an animal model of retinopathy induced by exposing rabbit retinas to insulin-like growth factor-I. Colloidal gold immunocytochemistry was used to quantify plasminogen activator-1 antigen in donor retinas from diabetic subjects (n = 10) and control subjects (n = 10). This technique was also used to examine expression of plasminogen activator inhibitor-1 for correlation with retinal changes in the insulin-like growth factor-I-induced retinopathy model (n = 14). Plasminogen activator inhibitor-1 immunoreactivity was significantly increased in the retinas of all diabetic subjects as compared to controls. In the rabbit model, the expression of plasminogen activator inhibitor-1 immunoreactivity correlated with pathological retinal changes. In both the diabetic human and insulin-like growth factor-1-injected rabbit, overproduction of plasminogen activator inhibitor-1 was seen within the lumen of capillaries, within the cytoplasm of endothelial cells and in the basement membrane and extracellular matrix surrounding these capillaries. Minimal plasminogen activator inhibitor-1 was detected in the retinas of non-diabetics and in control rabbits injected with either heat-inactivated insulin-like growth factor-I or balanced salt solution. These studies support the conclusion that plasminogen activator inhibitor-1 is overexpressed in the retinal capillaries of diabetics with nonproliferative diabetic retinopathy and in rabbits with insulin-like growth factor-I-induced retinopathy.

AB - Plasminogen activator inhibitor-1 is secreted bidirectionally by endothelial cells, acts as the primary regulator of fibrinolysis and as a key modulator of extracellular matrix proteolysis. Elevated farum levels of plasminogen activator inhibitor-1 are observed in serum of diabetic individuals. We investigated whether plasminogen activator inhibitor-1 is overexpressed in capillaries of diabetic donors with nonproliferative retinopathy compared to non-diabetic donors. We also assessed plasminogen activator inhibitor-1 expression in an animal model of retinopathy induced by exposing rabbit retinas to insulin-like growth factor-I. Colloidal gold immunocytochemistry was used to quantify plasminogen activator-1 antigen in donor retinas from diabetic subjects (n = 10) and control subjects (n = 10). This technique was also used to examine expression of plasminogen activator inhibitor-1 for correlation with retinal changes in the insulin-like growth factor-I-induced retinopathy model (n = 14). Plasminogen activator inhibitor-1 immunoreactivity was significantly increased in the retinas of all diabetic subjects as compared to controls. In the rabbit model, the expression of plasminogen activator inhibitor-1 immunoreactivity correlated with pathological retinal changes. In both the diabetic human and insulin-like growth factor-1-injected rabbit, overproduction of plasminogen activator inhibitor-1 was seen within the lumen of capillaries, within the cytoplasm of endothelial cells and in the basement membrane and extracellular matrix surrounding these capillaries. Minimal plasminogen activator inhibitor-1 was detected in the retinas of non-diabetics and in control rabbits injected with either heat-inactivated insulin-like growth factor-I or balanced salt solution. These studies support the conclusion that plasminogen activator inhibitor-1 is overexpressed in the retinal capillaries of diabetics with nonproliferative diabetic retinopathy and in rabbits with insulin-like growth factor-I-induced retinopathy.

KW - diabetic retinopathy

KW - immunocytochemistry

KW - insulin-like growth factor-I

KW - plasminogen activator inhibitor

KW - retinal endothelial cells

UR - http://www.scopus.com/inward/record.url?scp=0030248421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030248421&partnerID=8YFLogxK

U2 - 10.1006/exer.1996.0112

DO - 10.1006/exer.1996.0112

M3 - Article

C2 - 8943696

AN - SCOPUS:0030248421

VL - 63

SP - 233

EP - 244

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 3

ER -